Home >> About Us >> Our Clients

Our Clients

400,000
Business Professionals

Worked with 100% of the Top 10 Largest Biopharmaceutical Companies in the World

46 of Top 50 Pharmaceutical and Biotechnolgy companies

$40 million in Proprietary Benchmarking Research

>35,000
Benchmark Metrics

>3,500
Best Practices

From working with businesses in their infancy to working with some of the world's most successful companies, Best Practices, LLC has global experience benchmarking across organizations of all sizes. Our clients value our deep industry knowledge and functional expertise as well as our ability to uncover the best business practices of best-in-class organizations. Over the years, our clients and partners featured below have seen the value of best practice sharing and benchmarking through involvement with Best Practices, LLC.

Christopher Bogan

President and CEO

Chris has 26 years of experience in helping U.S. companies bring new biopharmaceutical products to market. Over that time, he has helped dozens of new brands launch assets totaling hundreds of billions of dollars.

Phone: (919)-767-9228

Schedule a Meeting

Pharmaceutical, Biotech & Medical Devices
Financial Services
Manufacturing
Technology
Telecom
Utilities
More

Abbott Laboratories
Actelion Pharmaceuticals
Alcon Laboratories
Alexion Pharmaceuticals
Allergan
Altana Pharmaceuticals
Amgen
Amylin
Astellas Pharmaceuticals
AstraZeneca
Bausch & Lomb
Baxter Healthcare
Bayer
Becton Dickinson
Biogen Idec
Blue Cross & Blue Shield
Boehringer Ingelheim
Boston Scientific
Corporation
Bristol-Myers Squibb

Cardinal Healthcare
Centocor
Convatec
Covance
Covidien
Daiichi Sankyo
DSM Pharmaceuticals
Eisai
Eli Lilly and Company
EMD Serono
Endo Pharmaceuticals
Ethicon Endo-Surgery Inc.
Forest Laboratories
Fujisawa Healthcare Inc.
Galderma
Genentech
Genzyme
Gilead Sciences
GlaxoSmithKline

Hospira
ImClone Systems
Janssen Pharmaceutica
Johnson & Johnson
King Pharmaceuticals
LifeScan
Lundbeck
Mallinckrodt.
Meda Pharmaceuticals Inc.
Medrad
Medtronic
Merck
Merck KGaA/EMD Serono
Millennium Pharmaceuticals
Novartis
Novo Nordisk
Onyx Pharmaceuticals
Ortho-McNeil Pharmaceuticals

Pfizer
Ranbaxy
Roche
Sandoz
Sanofi-aventis
Savient Pharmaceuticals
Shire Pharmaceuticals
Solvay Pharmaceuticals
Stiefel Laboratories
Takeda Pharmaceuticals
Talecris Biotherapeutics
Teva Pharmaceutical Industries
UCB Group
Valeant Pharmaceuticals
Vistakon
Warner Chilcott
Watson Pharmaceuticals

American Express
Bank One
Capital One
Citigroup
GE Money
Home Savings of America
JP Morgan Chase & Co.
KPMG
Merrill Lynch
MetLife
MONY

Morgan Stanley
Nationwide Insurance
Prudential
Smith Barney
TIAA-CREF
UBS
USAA
US Bank
Wachovia
Wells Fargo
Western Union

Boeing
General Electric
General Motors Company
Georgia-Pacific
Kraft
Lexmarkv
Lockheed Martin
Master Builders
Raytheon
Xerox

Cisco Systems
CSX Technology
Dell Computer Corporation
Electronic Data Systems (EDS)
Hewlett-Packard Company
IBM
Ingram Micro Inc.
Intel

Intuit
J.D. Edwards
Lucent Technologies Inc.
Micron Technology Inc.
Microsoft Corporation
NCR Corporation
NEC America
SCT

AT&T
Bell Atlantic
Bell Canada
BellSouth Corporation
Media One
Motorola Inc.
Nortel Networks
NYNEX/ Bell Atlantic
QUALCOMM
Sprint
Siemens AG
Verizon

CenterPoint Energy
Duke Energy
Florida Power & Light
Leeson Electric Corporation
LG&E Energy
Mirant
Progress Energy
Sacramento Municipal Utility District
Southern Company
TVA

BASF
Dupont
Federal Express Corporation
John F. Kennedy School of Government
International Monetary Fund
Mallinckrodt
Monsanto
Philip Morris International
Southeastern Freight Lines

1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
62FDA578E5DADDA3585256DFF006D6328
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/insights/clients?opendocument
18
19opendocument
2018.97.9.171
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25AUS